Abstract:Background CD80 and CD86 costimulatory molecules have an important role in T cell activation. Low or loss expression of CD80 and CD86 may lead to the occurrence of tumor immune escape. Objective To investigate the influence of CD80 and CD86 expression on the progression and prognosis of nasopharyngeal carcinoma(NPC). Methods 557 cases,who were diagnosed with nasopharyngeal carcinoma from January 2001 to December 2003 in Sun Yat-Sen University Cancer Center were selected in this study. The cases were pathologically confirmed diagnosis of nasopharyngeal carcinoma with biopsy specimens of corresponding clinical follow-up data. Patients were first diagnosed with NPC without any treatment. During the 2 to 114 months follow-up period,113 patients had distant organ metastasis,235 cases occurred to death. Immunohistochemical method was applied to detect CD80 and CD86 expression;Kaplan-Meier survival curve,the Log-rank test and single factor Cox proportional hazards regression analysis were adopted to analyze the relationship between the CD80 and CD86 expression and the progression and the prognosis of NPC patients. Results Immunohistochemical method found that CD80 and CD86 were mainly expressed in tumor cell membrane surface,but little expressed in tumor stroma. Among the 557 patients,309 cases in the low expression group of CD80 ,248 in the high expression group of CD80;470 cases in the low expression group of CD86 ,87 in the high expression group of CD86 . Kaplan-Meier survival curve and the Log-rank test results showed that there was no significant difference in the disease-free survival time between NPC patients in low expression group and high expression group of CD80 (χ2 =3. 551,P=0. 060);and there was significant difference in the overall survival time between NPC patients in low expression group and high expression group of CD80 (χ2 =5. 521,P=0. 019). There were no significant difference in disease-free survival time and the overall survival time between NPC patients in low expression group and high expression group of CD86 (χ2 =0. 948,P =0. 330;χ2=0. 662,P=0. 416). The results of single factor Cox proportional hazards regression analysis showed that the risk of metastasis and recurrence and death of NPC patients in high expression group of CD80 were higher those that of patients in low expression group of CD80(P﹤0. 05);there were no significant difference in the risk of metastasis and recurrence and death of NPC patients in low expression group and high expression group of CD86(P﹥0. 05). Spearman correlation analysis showed that CD86 of NPC tissues was positively correlated with CD68 + macrophages numbers in NPC stroma(rs =0. 103,P=0. 015). Conclusion High expression of CD80 in NPC tissues is negatively correlated with the prognosis of NPC patients,which increases the risk of local recurrence and distant metastasis. The relationship between expression of CD86 and the progression and prognosis of NPC patients is not found.

Associations of serum CD 62 P and IL-6 levels with nasopharyngeal carcinoma staging and prognosis

[Expression and Significance of Serum Sicam-1 and Scd4 & Scd8 in Patients with Nasopharyngeal Carcinoma].

Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma

High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations

A Prognostic Model Predicts the Risk of Distant Metastasis and Death for Patients with Nasopharyngeal Carcinoma Based on Pre-Treatment Interleukin 6 and Clinical Stage.

Expression of CD44V6 Protein in Nasopharyneal Carcinoma

Expression of p62/SQSTM I in nasopharyngeal carcinoma

[Clinical Significance of Quantitative Analysis of Serum VEGF, CD44s, and MMP-3 Protein in Nasopharyngeal Carcinoma].

Expression of P62 Protein in Nasopharyngeal Carcinoma and Its Clinical Significance

Detection of Serum Interleukin-10 Levels in Nasopharyngeal Carcinoma

Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis

Serum CCL2 and Serum TNF-α – Two New Biomarkers Predict Bone Invasion, Post-Treatment Distant Metastasis and Poor Overall Survival in Nasopharyngeal Carcinoma

[Scd40l, Sp-Selectin and Sicam-1 Plasma Levels in Nasopharyngeal Carcinoma].

Influence of CD80 and CD86 Expression on Progression and Prognosis of Nasopharyngeal Carcinoma

The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study

Prognostic Significance of Ki67 Expression and the Derived Neutrophil-Lymphocyte Ratio in Nasopharyngeal Carcinoma

Measurement of Serum Neopterin and Soluble Lymphocyte Antigens(sCD4 and sCD8) in Patients with Nasopharyngeal Carcinoma and Its Clinical Significance

Clinical Significance of Serum Hyaluronic Acid Level Alteration in Patient with Nasopharyngeal Carcinoma

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

P53, MDM2, Eif4e and EGFR Expression in Nasopharyngeal Carcinoma and Their Correlation with Clinicopathological Characteristics and Prognosis: A Retrospective Study